50 Deep Tech Startups in Cambridge to Watch in 2024

Transforming mental healthcare by unlocking the power of clinical data

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

Metrion Biosciences is a Contract Research Organization.

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

Supplant is a biotechnology platform that makes sugar substitutes.

Cancer diagnostics.

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Epitopea is a transatlantic cancer immunotherapeutics company.

PetMedix is a pet therapeutics startup.

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

Supplier of configurable process node agnostic analog IP building blocks.

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.

Novel cancer therapies.

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

Treatment for patients with chronic wounds.

Transine Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

MORPHOGEN-IX Limited is a drug discovery company founded in 2015 by Index Ventures to develop bone morphogenetic proteins

Molecular therapies for cancer patients.

Antibodies.com is a leading supplier of protein research tools.

A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology.

Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.

Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development.

Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

FiveAI provides a software platform designed for providing a solution in urban mobility in public transport to complex urban environments.

Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.

Nemesis Bioscience is a new biopharmaceutical company .

PetaGene’s mission is to make genomics data cheaper, faster and better.

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.

Spectral Edge combines patented Image Fusion tech with Deep Learning to reveal more of the color, detail and clarity in any image.